The investigational bi-functional fusion protein, SL-172154 (known as SIRPα-Fc-CD40L), is another immunomodulatory agent that operates by blocking the “do not eat me” signal on cancer cells (CD47/SIRPα) [206]. Here, SIRPA is linked to cancer.